27D-48280-35279
3 vaccinations
3 coded responses
35 check-ins
3 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 36-40
- ZIP prefix
- 468 / IN
- Registered
- 2020-12-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-19
Registered in v-safe
-
2020-12-19
Dose 1 — Pfizer-BioNTech
- 2020-12-19
-
2020-12-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2020-12-21
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2020-12-28
- 2021-01-02
-
2021-01-09
Dose 2 — Pfizer-BioNTech
- 2021-01-09
-
2021-01-10
Survey response — days 1–6 daily, dose 2MedDRA: Paraesthesia — Feeling: Good · Muscle or body achesFree text: Very, very mild tingling that is hard to distinguish from mild muscle aches. Feels most different in hands and feet.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-11
- 2021-01-15
- 2021-01-16
- 2021-01-23
- 2021-01-30
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-04-10
-
2021-07-10
Survey response — 6 months, dose 2MedDRA: Drainage, Dyspnoea, Lethargy, Respiratory tract congestion, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend schoolFree text: Head and cheat congestion, drainage, mild shortness of breath, lethargy. Rapid COVID antigen test negative. Rapid COVID antibody test positive for IgGMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-09-25
Dose 3 — Pfizer-BioNTech
- 2021-09-26
- 2021-09-27
- 2021-09-28
- 2021-09-29
-
2021-09-30
Survey response — days 1–6 daily, dose 3MedDRA: Vertigo — Feeling: GoodFree text: Mild sensation of vertigo. Very unusual for me, but also very mild. Simply trying to keep hydrated in case that might be the issue.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-01
- 2021-10-02
- 2021-10-09
- 2021-10-18
- 2021-10-23
- 2021-10-30
- 2021-11-06
- 2021-12-25
- 2022-03-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-09-25 | Pfizer-BioNTech | No |
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Very, very mild tingling that is hard to distinguish from mild muscle aches. Feels most different in hands and feet.
Release 9 — 6 months, dose 2
Symptoms: Head and cheat congestion, drainage, mild shortness of breath, lethargy. Rapid COVID antigen test negative. Rapid COVID antibody test positive for IgG
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Mild sensation of vertigo. Very unusual for me, but also very mild. Simply trying to keep hydrated in case that might be the issue.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Drainage | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Lethargy | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test positive | ✓ | ✓ | ✓ |
| SRO | Paraesthesia | ✓ | ✓ | ✓ |
| SRO | Vertigo | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release